Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (1): 88-96.doi: 10.13481/j.1671-587X.20240111

• Research in basic medicine • Previous Articles     Next Articles

Effect of soluble CD40 ligand on biological behavior of THP-1 cells through long non-coding RNA linc00239

Zhongxin FENG(),Mei LI   

  1. Department of Hematology,Affiliated Hospital,Guizhou Medical University,Guiyang 550004,China
  • Received:2023-04-11 Online:2024-01-28 Published:2024-01-31
  • Contact: Zhongxin FENG E-mail:fengsuyan2006@126.com

Abstract:

Objective To discuss the effect of CD40 ligand (CD40L) on the biological behavior of the human monocytic leukemia THP-1 cells through long non-coding RNA(lncRNA) linc00239,and to clarify its potential mechanism. Methods The linc00239 over-expression vector (pcDNA-linc00239) and interference vector (sh-linc00239) were constructed and transfected into the THP-1 cells.Real-time fluorescence quantitative PCR (RT-qPCR) method was used to detect the transfection efficiency. The THP-1 cells were divided into control group, vector group, pcDNA-linc00239 group, sh-linc00239 group, vector+CD40L group, pcDNA-linc00239+CD40L group, and sh-linc00239+CD40L group. RT-qPCR method was used to detect the expression levels of linc00239 in the cells in various groups; CCK-8 assay was used to detect the proliferation activities of the cells in various groups;flow cytometry was used to detect the percentages of the cells at different cell cycles and the apoptotic rates of the cells in various groups;RT-qPCR and Western blotting methods were used to to detect the expression levels of B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax) mRNA and proteins in the cells in various groups; Western blotting method was used to detect the expression levels of protein kinase B (AKT) and phosphorylated AKT (p-AKT) proteins in the cells in various groups,and the ratio of p-AKT/AKT was calculated. Results Compared with vector group, the proliferation activity of the cells and the percentage of the cells at G2 phase in pcDNA-linc00239 group were significantly increased (P<0.05 or P<0.01), the expression levels of linc00239, Bcl-2 mRNA and protein, and the ratio of p-AKT/AKT were significantly increased (P<0.05 or P<0.01),the percentage of the cells at G1 phase, apoptotic rate, and expression levels of Bax mRNA and protein in the cells were significantly decreased (P<0.05); compared with vector group, the proliferation activity of the cells and percentage of the cells at G2 phase, expression levels of linc00239, Bcl-2 mRNA and protein, and ratio of p-AKT/AKT in the cells in sh-linc00239 group and vector+CD40L group were significantly decreased (P<0.05 or P<0.01), while the percentage of the cells at G1 phase, apoptotic rate, and the expression levels of Bax mRNA and protein in the cells were significantly increased (P<0.05 or P<0.01);compared with pcDNA-linc00239 group, the proliferation activity of the cells and percentage of cells at G2 phase in pcDNA-linc00239+CD40L group were significantly decreased (P<0.05 or P<0.01), the expression levels of linc00239, Bcl-2 mRNA and protein,and ratio of p-AKT/AKT were significantly decreased (P<0.05 or P<0.01),while the percentage of cells at G1 phase, apoptotic rate, and the expression levels of Bax mRNA and protein were significantly increased (P<0.05 or P<0.01);compared with sh-linc00239 group, the proliferation activity of the cells and percentage of cells at G2 phase in sh-linc00239+CD40L group were significantly decreased (P<0.05 or P<0.01), the expression levels of linc00239, Bcl-2 mRNA and protein, and ratio of p-AKT/AKT were significantly decreased (P<0.05 or P<0.01),and the percentage of the cells at G1 phase, apoptotic rate, and expression levels of Bax mRNA and protein were significantly increased (P<0.05 or P<0.01). Conclusion CD40L can inhibit the proliferation and cell cycle progression of the THP-1 cells through linc00239 and induce the apoptosis.

Key words: CD40 ligand, Long non-coding RNA, linc00239, Acute myeloid leukemia, Cell cycle, Apoptosis

CLC Number: 

  • R733.71